C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+188.0%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
+188.0%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
198.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 36.31% |
| Q3 2025 | -23.62% |
| Q2 2025 | 1.15% |
| Q1 2025 | 23.87% |
| Q4 2024 | -40.16% |
| Q3 2024 | -39.23% |
| Q2 2024 | 37.53% |
| Q1 2024 | 18.40% |
| Q4 2023 | -28.54% |
| Q3 2023 | 24.73% |
| Q2 2023 | -3.28% |
| Q1 2023 | 6.47% |
| Q4 2022 | -16.36% |
| Q3 2022 | -16.58% |
| Q2 2022 | 13.31% |
| Q1 2022 | -101.94% |
| Q4 2021 | 36.56% |
| Q3 2021 | -9.31% |
| Q2 2021 | -7.67% |
| Q1 2021 | 3.78% |
| Q4 2020 | 0.18% |
| Q3 2020 | -102.31% |
| Q2 2020 | 9.39% |
| Q1 2020 | -18.85% |
| Q4 2019 | 0.70% |
| Q3 2019 | -11.04% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |